Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Boronow

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Behavioral Healthcare|April 9, 2008
The handwriting was on the wallGreg Merkle, John Boronow, David Bush
JAMA|December 28, 2016
Ensuring Staff Safety When Treating Potentially Violent PatientsRobert P Roca, Barbara Charen, John Boronow
Schizophrenia Research|October 13, 2006
The lymphotoxin Cys13Arg polymorphism and cognitive functioning in individuals with schizophreniaFaith Dickerson, John Boronow, Cassie Stallings, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 30, 2007
Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorderFaith Dickerson, Cassie Stallings, Andrea Origoni, et al.
Schizophrenia Bulletin|February 23, 2007
Toxoplasma gondii in individuals with schizophrenia: association with clinical and demographic factors and with mortalityFaith Dickerson, John Boronow, Cassie Stallings, et al.
Schizophrenia Research|May 11, 2007
C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophreniaFaith Dickerson, Cassie Stallings, Andrea Origoni, et al.
Schizophrenia Bulletin|September 17, 2005
Deficit schizophrenia: association with serum antibodies to cytomegalovirusFaith Dickerson, Brian Kirkpatrick, John Boronow, et al.
Biological Psychiatry|March 5, 2003
Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorderJoseph R Hibbeln, Kevin K Makino, Catherine E Martin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Behavioral Healthcare|April 9, 2008
The handwriting was on the wallGreg Merkle, John Boronow, David Bush
JAMA|December 28, 2016
Ensuring Staff Safety When Treating Potentially Violent PatientsRobert P Roca, Barbara Charen, John Boronow
Schizophrenia Research|October 13, 2006
The lymphotoxin Cys13Arg polymorphism and cognitive functioning in individuals with schizophreniaFaith Dickerson, John Boronow, Cassie Stallings, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 30, 2007
Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorderFaith Dickerson, Cassie Stallings, Andrea Origoni, et al.
Schizophrenia Bulletin|February 23, 2007
Toxoplasma gondii in individuals with schizophrenia: association with clinical and demographic factors and with mortalityFaith Dickerson, John Boronow, Cassie Stallings, et al.
Schizophrenia Research|May 11, 2007
C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophreniaFaith Dickerson, Cassie Stallings, Andrea Origoni, et al.
Schizophrenia Bulletin|September 17, 2005
Deficit schizophrenia: association with serum antibodies to cytomegalovirusFaith Dickerson, Brian Kirkpatrick, John Boronow, et al.
Biological Psychiatry|March 5, 2003
Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorderJoseph R Hibbeln, Kevin K Makino, Catherine E Martin, et al.
Pageof 1